AffinityImmuno Reveals Strong Preclinical Results

AffinityImmuno Reveals Strong Preclinical Results

Mice infected with COVID-19 saw as much as an 81 percent reduction in viral load.

AffinityImmuno Reveals Strong Preclinical Results

Read publication